Hsu Jason

DirectorImmix Biopharma, Inc. (IMMX) · full profile →Form 4 · filed Sep 18, 2023
Net Buying
Open-Market Buys
$200K
Open-Market Sells
$0
Net Open-Market Flow
$200K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 15, 2023Buy(P)7K$2.49$17K757K
Sep 14, 2023Buy(P)10K$2.58$26K750K
Sep 12, 2023Buy(P)30K$2.83$85K740K
Sep 11, 2023Buy(P)25K$2.89$72K710K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-032969) within minutes of acceptance. Every field above traces to the original document. Verify it directly: